A day after a vaccine maker hit pause on its COVID-19 clinical trial, the nation’s top health experts said Wednesday that the delay shows the degree of safety going into testing the candidate vaccines.
A day after a vaccine maker hit pause on its COVID-19 clinical trial, the nation’s top health experts said Wednesday that the delay shows the degree of safety going into testing the candidate vaccines.